Search Results
Sep 01, 2026, 09:18 ET Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress Test
www.dentek.com.About Prestige Consumer Healthcare Inc.Prestige Consumer Healthcare Inc. (NYSE: PBH) is a leading consumer healthcare company growing trusted, category-defining brands. Headquartered in New York, the Company markets, sells, manufactures
More news about: DenTek®
Aug 17, 2026, 12:25 ET Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering
well-capitalized to further the development of therapeutics for the treatment of diseases associated with dysfunctions in human metabolism, including PBH and gastroparesis. We are grateful to the Jones team for their partnership, commitment and execution throughout this process, and for helping us reach
More news about: JonesTrading Institutional Services
Aug 04, 2026, 16:30 ET BRISTOW GROUP REPORTS SECOND QUARTER 2026 RESULTS
28,889PBH amortization3,386
More news about: Bristow Group
Jul 07, 2026, 10:31 ET Post-Bariatric Hypoglycemia Market to Register Stunning Growth at a 16.4% CAGR Through 2036 Owing to the Emergence of Novel Drug Classes Such as GLP-1 Receptor Antagonists, SGLT1 Inhibitors, CRH Inhibitors, and SSTR5 Agonists | DelveInsight
Rising PBH Prevalence: The increasing prevalence of PBH, particularly among females, is a primary driver of PBH market expansion. In the US, in 2025, there were ~428,500 prevalent cases of PBH.Rising Opportunities in Targeted Therapies for PBH: Increasing insights into
More news about: DelveInsight Business Research, LLP
Jun 29, 2026, 10:54 ET Automotive Interior Material Market to Reach US$ 82.3 Bn by 2033 Driven by Premiumization and Sustainable Material Innovation - Persistence Market Research
USM, PMA), Distribution Type (Traditional Distribution, E-Commerce & Marketplaces, Pooling/Exchange Programs, Vendor-Managed Inventory, PBH/Material-by-the-Hour), Platform, End-user, and Regional Analysis for 2026 – 2033About Persistence Market Research:At
More news about: Persistence Market Research Pvt. Ltd.
Jun 25, 2026, 09:00 ET Prestige Consumer Healthcare Inc. (PBH) Clear Eyes® and Pillar5 Problems Drive Stock Lower, HBSS Investigating
www.hbsslaw.com/investor-fraud/pbhContact the Firm Now: [email protected] 844-916-0895Prestige Consumer Healthcare Inc. (PBH) Investigation:Prestige
More news about: Hagens Berman Sobol Shapiro LLP
Jun 11, 2026, 12:00 ET PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm
PBH) for violations of the securities laws.
More news about: The Schall Law Firm
Jun 11, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. ("Prestige" or the "Company") (NYSE: PBH). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jun 08, 2026, 12:19 ET PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm
PBH) for violations of the securities laws.
More news about: The Schall Law Firm
Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. ("Prestige" or the "Company") (NYSE: PBH). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
May 28, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. ("Prestige" or the "Company") (NYSE: PBH). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
May 22, 2026, 09:00 ET Prestige Consumer Healthcare, Inc. (PBH) Securities Fraud Investigation - Levi & Korsinsky
(NYSE: PBH) investors suffered significant losses when the stock dropped after the Company reported Q4 fiscal 2026 earnings well below expectations, with adjusted EPS of $1.23 versus the $1.39 consensus estimate and revenue of $281.6 million falling short of forecasts. If you lost money on your PBH investment,
More news about: Levi & Korsinsky, LLP
May 21, 2026, 18:40 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. ("Prestige" or the "Company") (NYSE: PBH). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
May 18, 2026, 09:00 ET PBH SHAREHOLDER INVESTIGATION: SueWallSt Investigates Prestige Consumer Healthcare for Possible Securities Law Violations
Ranked in ISS Top 50 for seven consecutive years.Frequently Asked Questions About the PBH Investigation Q: Who is eligible to participate in the PBH investigation? A: Investors who purchased PBH stock or securities and suffered financial losses may be eligible. Eligibility is based
More news about: SueWallSt.com
May 15, 2026, 19:02 ET Prestige Consumer Healthcare, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Prestige Consumer Healthcare (PBH)
predictions and were adequately disclosed to investors. When actual Q4 results were reported, PBH shares declined sharply. Q: Who is eligible to participate in the PBH investigation? A: Investors who purchased PBH stock or securities and suffered financial losses may be eligible. Eligibility is based
More news about: Levi & Korsinsky, LLP
May 05, 2026, 16:30 ET Bristow Group Reports First Quarter 2026 Results
24,386PBH amortization1,305
More news about: Bristow Group
Feb 25, 2026, 16:20 ET BRISTOW GROUP REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS
18,377PBH amortization1,542
More news about: Bristow Group
Feb 13, 2026, 11:26 ET Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market
accessibility curve include Doseology Sciences (CSE: MOOD), Amneal Pharmaceuticals (NASDAQ: AMRX), Prestige Consumer Healthcare (NYSE: PBH), Viking Therapeutics (NASDAQ: VKTX), and Insulet (NASDAQ: PODD).
More news about: Equity Insider
Nov 04, 2025, 16:30 ET Bristow Group Reports Third Quarter 2025 Results
PBH amortization
More news about: Bristow Group